Abstract:In recent years, special attention has been paid to non-invasive parenteral routes of administration, which are an alternative to injectable drugs, as well as other dosage forms whose effectiveness and safety may be compromised by the administration route. At the same time, there is a paradigm shift in relation to nasal dosage forms: they are no longer considered as primarily drugs exhibiting local effects, and an increasing number of nasal medici-nal products with systemic action are appearing on the market. There is a growing interest to the nasal delivery due to the possibility of maximizing the therapeutic potential of active substances that have proven themselves in clinical practice, for example, by quick targeted action to the site of the pathological process, increased bioavailability of the drug and reduced possible side effects. The nasal cavity as a site for systemic drug absorption has anatomical and physiological features that include a relatively large surface area, a porous endothelial basement membrane, a highly vascularized epithelial layer, high total blood flow, lack of first-pass metabolism, and easy access. Therefore, the development of a convenient (nasal) dosage form of the drug with a rapid onset of action is a promising approach. When developing a new pharmaceutical product, the factors that determine bioavaila-bility should be taken into account and addressed by appropriate formulation and delivery techniques: the use of mucoadhesive components or sub-stances that modulate mucociliary clearance, variation of the viscosity or osmolarity, or selection of an appropriate dosing device. Improving intrana-sal absorption is a promising direction for obtaining drugs with improved consumer properties. In addition to the functional properties of the formula-tions, safety aspects must also be taken into account. The article provides an analysis of the limiting factors for nasal preparations, strategies for in-creasing bioavailability, permeation enhancement mechanisms, and provides examples of the application of permeation enhancers used in developed and commercially available drugs. This review gives an idea on possible to use in nasal formulations permeation enhancers which have different mode of actions.

Insoluble Powder Formulation as an Effective Nasal Drug Delivery System

Development of In Vitro Evaluation System for Assessing Drug Dissolution Considering Physiological Environment in Nasal Cavity

Novel Nano-Spray-dried Powders for Efficient Pulmonary Drug Delivery.

Progress in nasal drug delivery systems

A Comprehensive Review of Advanced Nasal Delivery: Specially Insulin and Calcitonin

Nasal formulations for drug administration and characterization of nasal preparations in drug delivery.

Microfluidic Spray Dried And Spray Freeze Dried Uniform Microparticles Potentially For Intranasal Drug Delivery And Controlled Release

Spray Dried Levodopa-Doped Powder Potentially for Intranasal Delivery

Different Methods and Formulations of Drugs and Vaccines for Nasal Administration

Advances in polysaccharide-based formulations for intranasal drug delivery: A review

A Review on Nasal Self-Emulsifying Drug Delivery Systems: An Alternative Approach to Improve Brain Bioavailability of Poorly Water-Soluble Drugs

Influence of excipients on spray-dried powders for inhalation

Formulation of Dry Powders for Inhalation Comprising High Doses of a Poorly Soluble Hydrophobic Drug

Design and development of a chitosan-based nasal powder of dimethyl fumarate-cyclodextrin binary systems aimed at nose-to-brain administration. A stability study

Intranasal niosomes of nefopam with improved bioavailability: preparation, optimization, and in-vivo evaluation

DEVELOPMENT OF NASAL PHARMACEUTICAL PRODUCTS FOR SYSTEMIC EXPOSURE: USE OF PERMEATION ENHANCERS TO ACHIEVE TARGET PRODUCT PROFILE

Factors Affecting Nasal Drug Delivery and Design Strategies for Intranasal Drug Delivery.

[Studies on Formulations of Panax Notoginsenosides for Intranasal Administration].

Zolpidem Mucoadhesive Formulations for Intranasal Delivery: Characterization, in Vitro Permeability, Pharmacokinetics, and Nasal Ciliotoxicity in Rats

Optimization of formulation and device design for carrier-based nasal powder of influenza vaccine to maximize the delivery capability to the target site in the nasal cavity

Optimizing Intranasal Amisulpride Loaded Nanostructured Lipid Carriers: Formulation, Development, and Characterization Parameters